Subclinical Atherosclerosis and Brain Metabolism in Middle-Aged Individuals: The PESA Study

We tend to compartmentalize the heart and the brain. This study, from the large PESA cohort, shows how early they are linked — long before any symptom of either heart disease or dementia.

In 547 asymptomatic middle-aged adults, higher cardiovascular risk and greater carotid plaque burden were both associated with reduced brain glucose metabolism — and strikingly, the affected brain regions were the parietotemporal and cingulate areas that decline in Alzheimer’s disease. Hypertension was a particular driver. The associations held independent of standard risk factors, suggesting that silent vascular disease is already dampening brain function in midlife.

The implication is sobering and motivating: the same subclinical atherosclerosis that threatens the heart may be quietly compromising the brain decades before cognitive symptoms appear. It reframes cardiovascular prevention as brain protection too.

We rate the evidence strong for an observational study. Drawn from a well-characterized cohort with sophisticated imaging, it shows a compelling association — though, as cross-sectional analysis, it cannot prove that vascular disease causes the metabolic changes rather than sharing common roots.